{
    "code": "52027117",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027117",
    "time": "2023-12-14 19:48:18",
    "許可證字號": "衛部藥輸字第027117號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/06\/09",
    "發證\/登錄日期": "106\/06\/09",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202711702",
    "中文品名": "釋多糖持續性藥效膜衣錠10毫克\/1000毫克",
    "英文品名": "Xigduo XR Extended-Release Tablets 10mg\/1000mg",
    "適應症": "適用於配合飲食和運動，以改善以下第二型糖尿病成人\r\n病人的血糖控制： 已在接受dapagliflozin 和metformin\r\nhydrochloride(HCl)合併治療者，或使用metformin但控制\r\n不佳者。\r\n用於具第二型糖尿病且已有心血管疾病(CVD)或多重心\r\n血管風險因子的成人病人時，dapagliflozin可降低心衰竭\r\n住院的風險。",
    "劑型": "164持續性藥效膜衣錠",
    "包裝": "2-1000錠ALU-ALU鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新複方;",
    "監視期限": "",
    "主成分略述": "METFORMIN HYDROCHLORIDE WITH 0.5% MAGNESIUM STEARATE, Dapagliflozin propanediol monohydrate",
    "限制項目": "02輸　入 1L監視中新藥",
    "申請商名稱": "臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "製造廠名稱": "AstraZeneca Pharmaceuticals LP",
            "製造廠廠址": "4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "製造、包裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400720",
            "成分名稱": "METFORMIN HYDROCHLORIDE WITH 0.5% MAGNESIUM STEARATE",
            "含量描述": "",
            "含量": "1005.0400000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "6820602210",
            "成分名稱": "Dapagliflozin propanediol monohydrate",
            "含量描述": "",
            "含量": "12.3000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "027117 - Xigduo XR Tablets 10mg1000mg - 鋁箔-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027117&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Xigduo XR Extended-Release Tablets-109-04-21-109-11-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027117&Seq=005&Type=9"
        },
        {
            "title": "[核定版]Xigduo XR Extended-Release Tablets_20200421-109-04-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027117&Seq=004&Type=9"
        },
        {
            "title": "027117 - Xigduo XR Tablets 10mg1000mg - 外盒-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027117&Seq=004&Type=8"
        },
        {
            "title": "Xigduo XR Tablets 10mg1000mg 鋁箔-106-06-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027117&Seq=002&Type=8"
        },
        {
            "title": "Xigduo XR Tablets 10mg1000mg 外盒-106-06-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027117&Seq=001&Type=8"
        }
    ]
}